S-Bank Fund Management’s Elevance Health ELV Stock Holding History

S-Bank Fund Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$360K	Buy	+932	New	+$346K	0.05%	186

Other funds holding ELV

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return

S-Bank Fund Management's ELV Position: Q2 2026 in Review

S-Bank Fund Management opened a new position in Elevance Health (ELV) in Q2 2026: 932 shares worth $360K. The stake represents 0.05% of the portfolio and ranks #186 among its holdings.

808 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

S-Bank Fund Management held 932 shares of Elevance Health worth $360K as of Q2 2026.
Elevance Health was a new S-Bank Fund Management position in Q2 2026.
Elevance Health made up 0.05% of S-Bank Fund Management's portfolio in Q2 2026, its #186 holding.
808 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.